Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1981 1
1982 2
1983 2
1987 1
1989 1
1990 1
1993 3
1994 2
1995 3
1996 1
1997 1
1998 3
1999 7
2000 1
2001 5
2002 7
2003 5
2004 6
2005 3
2006 11
2007 11
2008 6
2009 5
2010 12
2011 9
2012 13
2013 15
2014 20
2015 14
2016 23
2017 23
2018 29
2019 31
2020 43
2021 52
2022 36
2023 28
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

397 results

Results by year

Filters applied: . Clear all
Page 1
Sex differences in immune responses.
Klein SL, Flanagan KL. Klein SL, et al. Among authors: flanagan kl. Nat Rev Immunol. 2016 Oct;16(10):626-38. doi: 10.1038/nri.2016.90. Epub 2016 Aug 22. Nat Rev Immunol. 2016. PMID: 27546235 Review.
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S. Esposito S, et al. Among authors: flanagan k. Front Immunol. 2022 Apr 28;13:880368. doi: 10.3389/fimmu.2022.880368. eCollection 2022. Front Immunol. 2022. PMID: 35572550 Free PMC article. Review.
The non-specific and sex-differential effects of vaccines.
Aaby P, Benn CS, Flanagan KL, Klein SL, Kollmann TR, Lynn DJ, Shann F. Aaby P, et al. Among authors: flanagan kl. Nat Rev Immunol. 2020 Aug;20(8):464-470. doi: 10.1038/s41577-020-0338-x. Epub 2020 May 27. Nat Rev Immunol. 2020. PMID: 32461674 Free PMC article. Review.
COVID-19 vaccines - are we there yet?
McIntyre P, Joo YJ, Chiu C, Flanagan K, Macartney K. McIntyre P, et al. Among authors: flanagan k. Aust Prescr. 2021 Feb;44(1):19-25. doi: 10.18773/austprescr.2020.084. Epub 2020 Dec 17. Aust Prescr. 2021. PMID: 33664546 Free PMC article. Review.
SARS-CoV-2 Vaccines: Where Are We Now?
Flanagan KL, MacIntyre CR, McIntyre PB, Nelson MR. Flanagan KL, et al. J Allergy Clin Immunol Pract. 2021 Oct;9(10):3535-3543. doi: 10.1016/j.jaip.2021.07.016. Epub 2021 Aug 13. J Allergy Clin Immunol Pract. 2021. PMID: 34400116 Free PMC article.
Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Moody R, Wilson K, Flanagan KL, Jaworowski A, Plebanski M. Moody R, et al. Among authors: flanagan kl. Int J Mol Sci. 2021 Aug 20;22(16):8965. doi: 10.3390/ijms22168965. Int J Mol Sci. 2021. PMID: 34445670 Free PMC article. Review.
Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines.
Benedicto-Matambo P, Bines JE, Malamba-Banda C, Shawa IT, Barnes K, Kamng'ona AW, Hungerford D, Jambo KC, Iturriza-Gomara M, Cunliffe NA, Flanagan KL, Jere KC. Benedicto-Matambo P, et al. Among authors: flanagan kl. Vaccines (Basel). 2022 Mar 10;10(3):418. doi: 10.3390/vaccines10030418. Vaccines (Basel). 2022. PMID: 35335050 Free PMC article. Review.
397 results